Skip to content
VuFind
Advanced
  • Management of ErbB2-positive b...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib
QR Code

Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib

Bibliographic Details
Main Authors: Vogel, C., Chan, Arlene, Gril, B., Kim, S., Kurebayashi, J., Liu, L., Lu, Y., Moon, H.
Format: Journal Article
Published: Oxford University Press 2010
Online Access:http://hdl.handle.net/20.500.11937/14131
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/14131

Similar Items

  • In silico study of the ErbB4 interactions with curcumin analogs
    by: Azman, Putri Arsyadian, et al.
    Published: (2015)
  • Comparison of tumour biomarker HER-2/neu (C-erbB-2) before and after surgery in breast cancer patients
    by: Aung, Sanda, et al.
    Published: (2014)
  • Detection of Human Papillomavirus, p53 and c-erbB-2 Protein Expression in Juvenile Laryngeal Papillomatosis: A Report of 2 Cases
    by: Siti Aishah Md Ali,, et al.
    Published: (2006)
  • Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer
    by: Chan, Arlene, et al.
    Published: (2014)
  • Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
    by: Azman, Nusaibah, et al.
    Published: (2022)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips